UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 189

Sortiert nach

Review article: loss of response to anti‐TNF treatments in Crohn’s disease

Alimentary pharmacology & therapeutics, 2011-05, Vol.33 (9), p.987-995

2011

Volltextzugriff (PDF)

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's & colitis, 2014-06, Vol.8 (6), p.443-468

2014

Volltextzugriff (PDF)

Early drug and anti‐infliximab antibody levels for prediction of primary nonresponse to infliximab therapy

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (2), p.212-218

2018

Volltextzugriff (PDF)

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española)

Revista de gastroenterología de México, 2014-10, Vol.79 (4), p.263-289

2014

Volltextzugriff (PDF)

Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.620-628

2014

Volltextzugriff (PDF)

The development and validation of screening tools for semi-automated surveillance of surgical site infection following various surgeries

Frontiers in medicine, 2023-01, Vol.10, p.1023385-1023385

2023

Volltextzugriff (PDF)

Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (2), p.276-282

2017

Volltextzugriff (PDF)

The immunogenic part of infliximab is the F(ab′)2, but measuring antibodies to the intact infliximab molecule is more clinically useful

Gut, 2011-01, Vol.60 (1), p.41-48

2011

Volltextzugriff (PDF)

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and colitis, 2009-06, Vol.3 (2), p.47-91

2009

Volltextzugriff (PDF)

Undetectable anti‐TNF drug levels in patients with long‐term remission predict successful drug withdrawal

Alimentary pharmacology & therapeutics, 2015-08, Vol.42 (3), p.356-364

2015

Volltextzugriff (PDF)

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis

Alimentary pharmacology & therapeutics, 2016-06, Vol.43 (12), p.1293-1299

2016

Volltextzugriff (PDF)

European evidence-based Consensus on the management of ulcerative colitis: Current management

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.24-62

2008

Volltextzugriff (PDF)

Editorial: anti‐tumour necrosis factor α antibodies – can efficacy be regained?

Alimentary pharmacology & therapeutics, 2017-06, Vol.45 (11), p.1473-1474

2017

Volltextzugriff (PDF)

Clinical characteristics of the West Nile fever outbreak, Israel, 2000

Emerging infectious diseases, 2001-07, Vol.7 (4), p.675-678

2001

Volltextzugriff (PDF)

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Gut, 2006-03, Vol.55 (suppl 1), p.i16-i35

2006

Volltextzugriff (PDF)

Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

The lancet. Gastroenterology & hepatology, 2022-07, Vol.7 (7), p.666-678

2022

Volltextzugriff (PDF)

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (6), p.714-722

2012

Volltextzugriff (PDF)

A novel device to improve colon cleanliness during colonoscopy

Endoscopy, 2012-07, Vol.44 (7), p.655

2012

Volltextzugriff (PDF)

Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review

Journal of antimicrobial chemotherapy, 2009-08, Vol.64 (2), p.239-250

2009

Volltextzugriff (PDF)

Validation of a semiautomated system for surveillance of surgical site infection after cesarean section

Infection control and hospital epidemiology, 2022-10, Vol.43 (10), p.1505-1507

2022

Volltextzugriff (PDF)

The loss of calretinin expression indicates aganglionosis in Hirschsprung’s disease

Journal of clinical pathology, 2004-07, Vol.57 (7), p.712-716

2004

Volltextzugriff (PDF)

Oral administration of non‐absorbable delayed release 6‐mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial

Clinical and experimental immunology, 2015-08, Vol.181 (2), p.362-372

2015

Volltextzugriff (PDF)

Taking immunogenicity assessment of therapeutic proteins to the next level

Biologicals, 2011-03, Vol.39 (2), p.100-109

2011

Volltextzugriff (PDF)

The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease

Cellular immunology, 2009, Vol.258 (2), p.115-122

2009

Volltextzugriff (PDF)

The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease

Cellular immunology, 2009, Vol.258 (2), p.115-122

2009

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(171)

Publikationsform

Artikel
(188)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(118)
Humans
(113)
Biological And Medical Sciences
(56)
Male
(52)
Female
(51)
Adult
(48)
Medical Sciences
(46)
Gastroenterology & Hepatology
(41)
Middle Aged
(39)
Aged
(30)
Immunology
(26)
Infectious Diseases
(23)
Israel - Epidemiology
(19)
Gastroenterology. Liver. Pancreas. Abdomen
(17)
Crohn's Disease
(16)
Pharmacology & Pharmacy
(15)
Adolescent
(14)
Microbiology
(14)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Review article: loss of response to anti‐TNF treatments in Crohn’s disease

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Early drug and anti‐infliximab antibody levels for prediction of primary nonresponse to infliximab therapy

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española)

Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease

The development and validation of screening tools for semi-automated surveillance of surgical site infection following various surgeries

Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab

The immunogenic part of infliximab is the F(ab′)2, but measuring antibodies to the intact infliximab molecule is more clinically useful

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Undetectable anti‐TNF drug levels in patients with long‐term remission predict successful drug withdrawal

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis

European evidence-based Consensus on the management of ulcerative colitis: Current management

Editorial: anti‐tumour necrosis factor α antibodies – can efficacy be regained?

Clinical characteristics of the West Nile fever outbreak, Israel, 2000

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD

A novel device to improve colon cleanliness during colonoscopy

Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review

Validation of a semiautomated system for surveillance of surgical site infection after cesarean section

The loss of calretinin expression indicates aganglionosis in Hirschsprung’s disease

Oral administration of non‐absorbable delayed release 6‐mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial

Taking immunogenicity assessment of therapeutic proteins to the next level

The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease

The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease

Suchergebnisse filtern